Glenmark Pharmaceuticals — Fact Sheet (March 2026)

2 slides from Glenmark Pharmaceuticals's fact sheet, March 2026

Slide 1: Focused on innovation and accessibility
focused on innovation and accessibility As a global, research-led pharmaceutical 11 6 16000+ company, we pioneer transformative Manufacturing R&D Employees breakthrough therapies that aim to redefine facilities centres (Global) treatment while expanding access to 80+ 50+ high-quality and affordable
Slide 2: Global Presence, Market Leadership, CSR and Sustainability
Global Presence Vysoké Mýto, Czech Republic Neuchatel Lausanne, Switzerland Monroe, USA New York India 8 Formulations facilities 3 R&D centers Pilar, Argentina All maps are for representational purpose only. Depiction of boundaries is not authoritative. Goa | Sikkim | Indore | Nalagarh | Pilar | Mon